Skip to main content
Gujarat Themis Biosyn Ltd. logo

Gujarat Themis Biosyn Ltd. — Investor Relations & Filings

Ticker · GUJTHEM ISIN · INE942C01045 LEI · 3358009IT99XRO254Q79 BSE.NS Manufacturing
Open in API
Filings indexed 699 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country IN India
Listing BSE.NS GUJTHEM

About Gujarat Themis Biosyn Ltd.

https://www.gtbl.in

Gujarat Themis Biosyn Ltd. specializes in the manufacture of active pharmaceutical ingredients and intermediates through advanced fermentation technology. The company focuses on the production of fermentation-based bulk drugs, with a primary product portfolio that includes Rifampicin intermediates and Lovastatin. Utilizing large-scale fermentation processes, the organization engages in strain improvement and media optimization to enhance yield and efficiency. The company operates a dedicated manufacturing facility equipped for complex biotechnological processes. Through technical collaborations with international entities, it has integrated specialized expertise in fermentation science to support the development of high-purity chemical compounds. Its operations are centered on providing essential building blocks for various therapeutic applications, maintaining a focus on technical precision and process-driven manufacturing excellence.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal compliance disclosure under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, notifying the stock exchanges of the incorporation of a wholly owned subsidiary in Ireland. It does not contain financial statements, transaction details like a financing update, nor is it an M&A or capital-raising document; it is a regulatory announcement to the exchanges. This best fits the generic Regulatory Filings category.
2026-05-29 English
Please refer to the attachment.
Regulatory Filings Classification · 65% confidence The document is a formal stock exchange disclosure under SEBI Listing Regulations (Regulation 30) notifying the incorporation of a wholly owned subsidiary in Ireland. It is not an annual or interim report, not an earnings release, and contains no financial statements—rather it is a regulatory announcement of a corporate event. This falls under the catch-all category for miscellaneous regulatory filings under “Regulatory Filings (RNS).”
2026-05-29 English
Annual Secretarial Compliance Report for the financial year ended 31.03.2026
Regulatory Filings Classification · 95% confidence The document is a letter submitted to stock exchanges containing a Practicing Company Secretary’s Annual Secretarial Compliance Report under SEBI Listing Obligations. It is an attestation/certification of regulatory compliance rather than an annual/quarterly financial report or management presentation. Under the “Certification Rule,” officer certifications and compliance attestations should be classified as Regulatory Filings (RNS), making this the appropriate category.
2026-05-29 English
Newspaper Publication of audited financial results for the quarter and year ended 31st March, 2026
Report Publication Announcement Classification · 90% confidence The document is a brief cover letter dated 26 May 2026 to India’s stock exchanges informing them that the audited quarterly and annual financial results for the period ended 31 March 2026 have been published in newspapers, with copies enclosed. No actual financial data or analysis is contained in the text itself. This matches the pattern of a “report publication announcement” (RPA) under the Filing Definitions, where a company notifies the publication or availability of a report rather than providing the report’s contents.
2026-05-26 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 87% confidence The document is a short letter from the company secretary to stock exchanges dated 26 May 2026 stating that copies of the newspaper publication of audited financial results for the quarter and year ended 31 March 2026 are enclosed. It does not contain the actual financial statements or detailed results but merely announces their publication in newspapers. This fits the definition of a Report Publication Announcement (RPA), rather than the full annual or interim report or any other category.
2026-05-26 English
Investor Presentation
Investor Presentation Classification · 92% confidence The document is a slide-based presentation titled “Investor Presentation” for Q4 & FY2025-26, submitted under SEBI Listing Regulation 30 to the stock exchanges. It contains forward-looking statements, financial highlights, management commentary, deal snapshots, and strategic outlook—features characteristic of an investor presentation deck rather than a standalone earnings release or formal report. It does not serve as a transcript, audit report, or proxy statement, so it fits the “Investor Presentation” category.
2026-05-25 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.